These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35397747)

  • 21. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.
    Chen YW; Hsiao PJ; Weng CC; Kuo KK; Kuo TL; Wu DC; Hung WC; Cheng KH
    BMC Cancer; 2014 Mar; 14():181. PubMed ID: 24625091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
    Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
    Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of clusterin inhibits the growth and migration of renal carcinoma cells and leads to differential gene expression.
    Shi H; Deng JH; Wang Z; Cao KY; Zhou L; Wan H
    Mol Med Rep; 2013 Jul; 8(1):35-40. PubMed ID: 23670677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux.
    Carozzo A; Yaneff A; Gómez N; Di Siervi N; Sahores A; Diez F; Attorresi AI; Rodríguez-González Á; Monczor F; Fernández N; Abba M; Shayo C; Davio C
    Mol Pharmacol; 2019 Jul; 96(1):13-25. PubMed ID: 31043460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
    FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease.
    Pucci S; Greggi C; Polidoro C; Piro MC; Celi M; Feola M; Gasbarra E; Iundusi R; Mastrangeli F; Novelli G; Orlandi A; Tarantino U
    J Transl Med; 2019 Apr; 17(1):118. PubMed ID: 30967152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MCOLN1 Promotes Proliferation and Predicts Poor Survival of Patients with Pancreatic Ductal Adenocarcinoma.
    Hu ZD; Yan J; Cao KY; Yin ZQ; Xin WW; Zhang MF
    Dis Markers; 2019; 2019():9436047. PubMed ID: 31481985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.
    Huang MB; Gonzalez RR; Lillard J; Bond VC
    Oncotarget; 2017 Feb; 8(7):11302-11315. PubMed ID: 28076321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Clusterin/NF-κB in the secretion of senescence-associated secretory phenotype in Cr(VI)-induced premature senescent L-02 hepatocytes.
    Liang Y; Liang N; Ma Y; Tang S; Ye S; Xiao F
    Ecotoxicol Environ Saf; 2021 Aug; 219():112343. PubMed ID: 34020271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
    Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lentivirus-mediated RNA interference of clusterin enhances the chemosensitivity of EJ bladder cancer cells to epirubicin in vitro.
    Lu J; Luo JH; Pang J; Cao JZ; Wu RH; Tong ZT; Chen W; Xie D
    Mol Med Rep; 2012 Nov; 6(5):1133-9. PubMed ID: 22895628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinoma.
    Maftouh M; Belo AI; Avan A; Funel N; Peters GJ; Giovannetti E; Van Die I
    Oncotarget; 2014 Jul; 5(14):5335-49. PubMed ID: 24977327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
    Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
    PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a pyridine derivative inducing senescence in ovarian cancer cell lines via P21 activation.
    Shang D; Wu Y; Ding Y; Lu Z; Shen Y; Zhu F; Liu H; Zhu C; Tu Z
    Clin Exp Pharmacol Physiol; 2018 May; 45(5):452-460. PubMed ID: 29143360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogene-Induced Senescence Limits the Progression of Pancreatic Neoplasia through Production of Activin A.
    Zhao Y; Wu Z; Chanal M; Guillaumond F; Goehrig D; Bachy S; Principe M; Ziverec A; Flaman JM; Collin G; Tomasini R; Pasternack A; Ritvos O; Vasseur S; Bernard D; Hennino A; Bertolino P
    Cancer Res; 2020 Aug; 80(16):3359-3371. PubMed ID: 32554750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
    Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
    Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis.
    Ikezawa K; Hikita H; Shigekawa M; Iwahashi K; Eguchi H; Sakamori R; Tatsumi T; Takehara T
    Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):185-200.e1. PubMed ID: 28948203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KIF4A Regulates the Progression of Pancreatic Ductal Adenocarcinoma through Proliferation and Invasion.
    Chen J; Zhao CC; Chen FR; Feng GW; Luo F; Jiang T
    Biomed Res Int; 2021; 2021():8249293. PubMed ID: 34805404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma.
    Li C; Dong Q; Che X; Xu L; Li Z; Fan Y; Hou K; Wang S; Qu J; Xu L; Wen T; Yang X; Qu X; Liu Y
    BMC Cancer; 2018 Jun; 18(1):681. PubMed ID: 29940895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.